MAUI Imaging Secures $14 Million in Funding for Revolutionary Ultrasound Technology

MAUI Imaging, an innovative company specializing in advanced imaging technology, recently announced its successful round of funding, securing $14 million in a Series D investment led by Acertara Acoustic Laboratories. This funding aims to expand the production, sales, and marketing of its unique Computed Echo Tomography (CET)-based imaging technology. This breakthrough technology is designed to visualize anatomical features that traditional ultrasound systems cannot capture, addressing a significant gap in the medical imaging landscape.

Addressing Critical Needs in Trauma Medicine

The CEO and co-founder of MAUI Imaging, David Specht, shared his enthusiasm for this latest development, emphasizing the importance of their technology in trauma medicine. He noted that the collaboration with the U.S. military underlines the need for advanced imaging systems capable of delivering rapid and detailed insights into various types of tissues during emergencies. With the support from Acertara, MAUI Imaging can better cater to hospitals' needs across the country. The technology's potential to save lives and enhance patient outcomes is profound, particularly in trauma situations where quick diagnosis is crucial.

Acertara Acoustic Laboratories has also pledged to handle pre-orders for the MAUI ultrasound system, which will be distributed exclusively to hospitals outside of those directly served by MAUI Imaging. Levi Moore, President and CEO of Acertara, emphasizes that